Welcome to TGC's network
Proprietary Cannabinoid Tablet Delivery Platform for Clinical Development
Welcome to TGC's network
Proprietary Cannabinoid Tablet Delivery Platform for Clinical Development
Who We Are at TGC Network
TGC Network has developed a patented oral delivery system designed to enable precise dosing, improved bioavailability, and scalable manufacturing of cannabinoid-based therapeutics.
Patented
Backed by U.S. Patents No. 11,179,340 B2 and 12,220,488 B2
Our Expertise
TGC Network is advancing a novel tablet-based formulation platform for cannabinoids, addressing key limitations in traditional delivery methods such as inconsistent absorption, delayed onset, and variable dosing.
Our technology is designed to support development of regulated therapeutic products across multiple indications, with a focus on reproducibility, stability, and patient compliance.
We are actively seeking strategic partners for clinical development, licensing, and global commercialization.